Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy
- PMID: 22619083
- PMCID: PMC3402260
- DOI: 10.2337/dc11-1791
Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy
Abstract
Objective: Depression affects up to 20-25% of adults with type 2 diabetes and may increase all-cause mortality, but few well-designed studies have examined the effects of depression on the full range of cardiovascular disease outcomes in type 2 diabetes.
Research design and methods: A total of 2,053 participants in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Health-Related Quality of Life substudy completed the Patient Health Questionnaire (PHQ)-9 measure of depression symptoms at baseline and 12, 36, and 48 months. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) (95% CI) for the time-varying impact of depression on protocol-defined clinical outcomes with and without adjustment for demographic, trial-related, clinical, and behavioral variables.
Results: In fully adjusted models, depression was not significantly related to the ACCORD primary composite outcome (cardiovascular death, nonfatal heart attack, or stroke) (HR 1.53 [95% CI 0.85-2.73]) or to the ACCORD microvascular composite outcome (0.93 [0.53-1.62]), but all-cause mortality was significantly increased both in those with PHQ-assessed probable major depression (2.24 [1.24-4.06]) and PHQ score of ≥ 10 (1.84 [1.17-2.89]). The effect of depression on all-cause mortality was not related to previous cardiovascular events or to assignment to intensive or standard glycemia control. Probable major depression (by PHQ-9) had a borderline impact on the ACCORD macrovascular end point (1.42 [0.99-2.04]).
Conclusions: Depression increases the risk of all-cause mortality and may increase the risk of macrovascular events among adults with type 2 diabetes at high risk for cardiovascular events.
Trial registration: ClinicalTrials.gov NCT00000620.
References
-
- Eaton WW. Epidemiologic evidence on the comorbidity of depression and diabetes. J Psychosom Res 2002;53:903–906 - PubMed
-
- Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069–1078 - PubMed
-
- Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:934–942 - PubMed
-
- Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004;27:2154–2160 - PubMed
-
- de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63:619–630 - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- N01 HC095179/HL/NHLBI NIH HHS/United States
- N01 HC095184/HL/NHLBI NIH HHS/United States
- N01-HC-95180/HC/NHLBI NIH HHS/United States
- N01 HC095178/HL/NHLBI NIH HHS/United States
- N01-HC-95184/HC/NHLBI NIH HHS/United States
- IAA-Y1-HC-1010/HC/NHLBI NIH HHS/United States
- N01 HC095182/HL/NHLBI NIH HHS/United States
- N01-HC-95183/HC/NHLBI NIH HHS/United States
- N01-HC-95178/HC/NHLBI NIH HHS/United States
- N01-HC-95179/HC/NHLBI NIH HHS/United States
- N01-HC-95181/HC/NHLBI NIH HHS/United States
- IAA-Y1-HC-9035/HC/NHLBI NIH HHS/United States
- N01 HC095180/HL/NHLBI NIH HHS/United States
- Y01 HC001010/HC/NHLBI NIH HHS/United States
- Y01 HC009035/HC/NHLBI NIH HHS/United States
- N01 HC095181/HL/NHLBI NIH HHS/United States
- N01-HC-95182/HC/NHLBI NIH HHS/United States
- N01 HC095183/HL/NHLBI NIH HHS/United States
